Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Ileocolic Neobladder ÀÇ 5³â°£ °æÇè The Ileocolic Neobladder: 5-Year Experience in 49 Male Bladder Cancer Patients

´ëÇѺñ´¢±â°úÇÐȸÁö 1997³â 38±Ç 11È£ p.1210 ~ 1216
À̰Ǽ·, ¾çÀϱÇ, ¹æÀçÈ«,
¼Ò¼Ó »ó¼¼Á¤º¸
À̰Ǽ· (  ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

¾çÀϱǠ(  ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
¹æÀçÈ« (  ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

Abstract

°á·Ð
ÀúÀÚµéÀº 1991³â 5¿ùºÎÅÍ 1996³â 4¿ù±îÁö 5³â°£ ¹æ±¤¾Ï ȯÀÚ¿¡¼­ ±ÙÄ¡Àû ¹æ±¤ÀûÃâ¼úÈÄÀÇ
¿ä·ÎÀüȯ¼ú·Î 49·ÊÀÇ ileocolic neobladder¸¦ ½ÃÇàÇϸç À̸¦ ´ë»óÀ¸·Î ¼úÈÄ ÇÕº´Áõ°ú ¿ä¿ªµ¿
ÇÐÀû °Ë»ç¸¦ ºÐ¼®ÇÏ¿´´Ù. ¼úÈÄ Ãʱâ ÇÕº´ÁõÀº 8·Ê(16.7%)¿¡¼­ ¹ß»ýÇÏ¿´À¸³ª ÀÌÁß 7·Ê´Â
neobladder¿Í ¿¬°üÀÌ ¾ø´Â ÇÕº´ÁõÀ̾úÀ¸¸ç ´ëºÎºÐ º¸Á¸ÀûÀ¸·Î Ä¡À¯µÇ¾ú´Ù. ¼úÈÄ Èıâ ÇÕº´
ÁõÀº 10·Ê(20.9·Ê)¿¡¼­ ¹ß»ýµÇ¾úÀ¸¸ç ¿ä°ü-Àå ¹®ÇÕºÎÀ§ÀÇ ÇùÂøÀÌ 5·Ê (10.4%)·Î °¡Àå ¸¹¾Ò
°í ¿ä°ü È®Àå¼ú ¹× ¿ä°ü-Àå Àç¹®ÇÕ¼ú·Î Ä¡·áÇÏ¿´´Ù. ¼úÈÄ 6°³¿ù¿¡ °Ë»çÇÑ ¿ä¿ªµ¿ÇÐÀû °Ë»ç
¿¡¼­ neobladderÀÇ Æò±Õ ÃÖ´ë¿ëÀûÀº 553¡¾75.3 ml, Æò±Õ ÃÖ´ë³»¾ÐÀº 24.2¡¾6.7 §¯
H2O, Æò±Õ ÃÖ´ë¿äµµÆó¼â¾Ð 51.4¡¾12.7 §¯H2O, Æò±Õ ÃÖ´ë¿ä¼Ó
11.3¡¾6.5m1/sec ¹× Æò±Õ ÀÜ´¢·® 46.5¡¾8.1 ml·Î½á ºñ±³Àû Å« ¿ëÀû°ú ³·Àº ³»¾ÐÀ» º¸¿´°í ÁÖ
°£ ¿äÀÚÁ¦À²Àº 100%, ¾ß°£ ¿äÀÚÁ¦À²Àº 91.7%¸¦ º¸¿´´Ù.
ÀÌ»óÀÇ °á°ú·Î ÀúÀÚµéÀÌ ½ÃÇàÇÑ ileocolic neobaldder´Â ¼ö¼úÈÄ ÇÕº´ÁõÀÇ ºóµµ°¡ ±âÁ¸ÀÇ ´Ù
¸¥ ¿ä·ÎÀüȯ¼ú°ú ºñ±³ÇÏ¿© Å« Â÷ÀÌ°¡ ¾øÀ¸¸ç ³·Àº reservoir ³»¾Ð°ú ³ôÀº ¿äµµ Æó¼â¾ÐÀ¸·Î
¿äÀÚÁ¦¸¦ À¯ÁöÇÒ ¼ö ÀÖ°í »óµÎ¿ä·Î¸¦ º¸È£ÇÒ ¼ö ÀÖ¾î ¹æ±¤ÀûÃâ¼úÀÌ ¿ä±¸µÇ´Â ºñ±³Àû Àþ°í
Àü½Å »óÅ°¡ ¾çÈ£ÇÑ È¯ÀÚ¿¡¼­ ±ÇÇÒ¸¸ÇÑ ¼ö¼ú¹ýÀ¸·Î »ý°¢µÈ´Ù.
#ÃÊ·Ï#
Since 1991 the orthotopic ileocolic neobladder after radical cystoprostatectomy for
bladder cancer has been performed at our hospital. We report our 5 year experience of
ileocolic neobladder with focus on complications, urodynamic data and continence status.
Between May 1991 and April 1996, a total of 49 men underwent bladder replacement
with an orthotopic ileocolic neobladder following radical cystectomy for management of
invasive bladder cancer.
Mean age of the patient was 53.2 years (range 34¡­68). Mean follow up was 42
months (range 4¡­63). There was one perioperative death due to sepsis who had been
suffered from diabetes mellitus. Early complications were developed in 8 patients(16.7%);
neobladder leak in 1(2.1%), wound infection in 2 (4.2%), wound dehiscence in 2 (4.2%),
prolonged ileus in 1 (2.1%), and pneumonia in 1 (2.1%). Neobladder-related late
complications requiring rehospitalization were noted in 7 patients (14.6%); cecourethral
anastomosis site stricture in 1 (2.1%) which was treated endoscopically, urethral
strictures at the reimplantation site in 5 (7 renal unites, 10.4%) which were successfully
treated with balloon dilation in 4 patients and with open revision in 1 patient, and
neobladder perforation in 1 (2.1%) which was managed conservatively without sequelae.
Urethral recurrence was noted in 1 patient and has been managed with M-VAC
chemotherapy. There was no vesicoureteral reflux in any patient.
Urodynamic study of the neobladder at 6 months showed a low pressure (mean 24.2
§¯ H2O), large capacity (mean 553 ml) and an adequate maximal urethral
closure pressure(mean 51.3 §¯ H2O). The peak flow rate in all patients
was good (mean 11.3m/sec). All patients were dry during daytime but mild stress
urinary incontinence was noted in 5 patients (10.4%) and nighttime continence was good
in 91.7% at 6 months. Our results indicate that orthotopic ileocolic neobladdcr provides
good functional results and would be one of the ideal urinary diversion for bladder
substitution after radical cystoprostatectomy and will continue to be our procedure of
choice in selected male bladder cancer patients.

Å°¿öµå

Bladder cancer; Ileocolic neobladder;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS